SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
September 17, 2003 (Date of earliest event reported)
Commission File Number 000-19627
BIOLASE TECHNOLOGY, INC.
(Exact Name of Registrant as Specified in Its Charter)
| Delaware | 000-19627 | 87-0442441 | ||
(State or Other Jurisdiction of Incorporation or Organization) | (Commission file number) | (I.R.S. Employer Identification No.) |
981 Calle Amanecer
San Clemente, California 92673
(Address of Principal Executive Offices, Including Zip Code)
(949) 361-1200
(Registrant’s Telephone Number, Including Area Code)
Item 7. Financial Statements and Exhibits.
| (c) | Exhibits. |
| 99.1 | Press Release, dated September 17, 2003. |
Item 12. Results of Operations and Financial Condition.
On September 17, 2003, BioLase Technology, Inc. issued a press release announcing that it filed an amended 10-K and amended 10-Q’s to restate financial statements for periods to account for differences in revenue recognition. A copy of the press release is attached herewith as Exhibit 99.1.
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
Dated: September 17, 2003 | BIOLASE TECHNOLOGY, INC., (Registrant) | |||||||
By: | /s/ EDSON J. ROOD | |||||||
Edson J. Rood Vice President and Chief Financial Officer (Principal Financial and Accounting Officer) | ||||||||
3